Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries

BACKGROUND: Respiratory syncytial virus (RSV) frequently causes acute lower respiratory infection in children under 5, representing a high burden in Gavi-eligible countries (mostly low-income and lower-middle-income). Since multiple RSV interventions, including vaccines and monoclonal antibody (mAb)...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiao, Willem, Lander, Antillon, Marina, Bilcke, Joke, Jit, Mark, Beutels, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132892/
https://www.ncbi.nlm.nih.gov/pubmed/32248817
http://dx.doi.org/10.1186/s12916-020-01537-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132892/
https://www.ncbi.nlm.nih.gov/pubmed/32248817
http://dx.doi.org/10.1186/s12916-020-01537-6

Ejemplares similares